Xsensio
Latest round
- Series A
Last raised
- Mar 2026
Total raised
- $7M
Investors
- 3
About Xsensio
A.A. specializes in healthcare technology, particularly in the realm of continuous health monitoring.A. Xsensio specializes in advanced healthcare technologies, primarily offering its flagship product, the Lab-on-Skin™ sensing platform. This innovative platform is designed for real-time, continuous monitoring of critical biomarkers, such as inflammation, enabling earlier detection of clinical deterioration across diverse settings, including ICUs, outpatient care, and home environments. The Lab-on-Skin™ sensing chip, developed at the Nanolab of the Swiss Federal Institute of Technology, utilizes semiconductor-based technology to provide unprecedented capabilities in health monitoring. The platform is particularly aimed at addressing high-impact challenges in critical care, oncology, and post-surgical recovery, serving a client base that includes healthcare providers and institutions seeking to enhance patient monitoring.Xsensio’s revenue model is structured around B2B transactions, primarily targeting healthcare facilities and providers. The company generates income through the sales of its Lab-on-Skin™ sensing platform, which may involve direct sales agreements or partnerships with healthcare institutions. These transactions are designed to provide clients with actionable data that can facilitate timely clinical decisions. While specific pricing plans for individual products or services are not disclosed, the value proposition of the Lab-on-Skin™ technology is focused on improving patient outcomes and efficiency in monitoring, which is critical for healthcare providers. The revenue from these transactions is driven by the growing demand for continuous health monitoring solutions in healthcare systems across the regions served. The company is focused on introducing new products that enhance health monitoring capabilities, although specific details about upcoming product releases have not been disclosed. Moreover, Xsensio aims to expand its presence beyond current markets in Europe and North America, with specific geographic regions targeted for future growth expected to be identified based on demand.
Who invested in Xsensio
3 investors across 1 round
See all investors in Xsensio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 2, 2026
Amount
$7M
Investors
Questions about Xsensio
Who invested in Xsensio?
Xsensio has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xsensio raised?
Xsensio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Xsensio last raise money?
Xsensio's most recent round on record is a Series A, in Mar 2026.
What does Xsensio do?
Xsensio is a healthcare it company.
Where is Xsensio headquartered?
Xsensio is headquartered in Lausanne, Switzerland.
Which VCs invest in companies like Xsensio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back healthcare it companies at Xsensio's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Xsensio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.